Article
Use of MTHFR C677T polymorphism and plasma pharmacokinetics to predict methotrexate toxicity in patients with acute lymphoblastic leukemia.
Advances in clinical and experimental medicine : official organ Wroclaw Medical University - 1 Aug 2018
Mahmoud Lobna Ben, Mdhaffar Moez, Frikha Rim, Ghozzi Hanen, Hakim Ahmed, Sahnoun Zouheir, Elloumi Moez, Zeghal Khaled
Abstract excerpt
BACKGROUND: Methotrexate (MTX) is a key component of acute lymphoblastic leukemia (ALL) therapy, but it is associated with serious toxicities in a considerable number of patients. OBJECTIVES: The aim of the current study was to determine which variables were associated with MTX toxicity in children, adolescents and young adults with ALL. MATERIAL AND METHODS: In this prospective study, 35 patients with newly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
